The announcement comes just two weeks after Merck pulled its painkiller, Vioxx, which is in the same class of drugs as Bextra, from the market because a study showed that the risk of heart attacks doubled for patients who had taken Vioxx for 18 months or longer.
The FDA said last week after Vioxx was withdrawn that the problems were unique to that drug.
With Vioxx, researchers had been warning about the drug's possible cardiovascular risks since 2000, only a year after it was approved by the FDA.
Other drugs besides Vioxx may raise heart risks, report suggests Merck, which
